CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
511-525 of 1225
Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC
MinuteCE®Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC
Komal Jhaveri, MD, FACP
Kevin Kalinsky MD, MS
PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
MinuteCE®PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
Komal Jhaveri, MD, FACP
Kevin Kalinsky MD, MS
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
MinuteCE®Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
Komal Jhaveri, MD, FACP
Kevin Kalinsky MD, MS
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
MinuteCE®Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
Komal Jhaveri, MD, FACP
Kevin Kalinsky MD, MS
PI3K Pathway Inhibitors: Safety and Tolerability Profiles
MinuteCE®PI3K Pathway Inhibitors: Safety and Tolerability Profiles
Komal Jhaveri, MD, FACP
Kevin Kalinsky MD, MS
Komal Jhaveri, MD, FACP
Kevin Kalinsky MD, MS
- advertisement
Understanding Endocrine Resistance in HR+/HER2- mBC
MinuteCE®Understanding Endocrine Resistance in HR+/HER2- mBC
Kevin Kalinsky MD, MS
The Future of PI3K Inhibition in HR+/HER2- Breast Cancer
MinuteCE®The Future of PI3K Inhibition in HR+/HER2- Breast Cancer
Komal Jhaveri, MD, FACP
Kevin Kalinsky MD, MS
Behind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies
CME/CEBehind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies
Irene Caruso
Advances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
CME/CEAdvances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
Marwan Sabbagh, MD, FAAN
Christoph U. Correll, MD
Alireza Atri, MD, PhD
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
CME/CEReal-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Crossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
CME/CE Broadcast ReplayCrossing Boundaries: CETP Inhibitors and the Next Frontier in Lipid Control
Prof. Ulrich Laufs
Pam R. Taub, MD, FACC, FASPC
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Christie Ballantyne, MD
- advertisement
New Insights in the Management of HCM: Exploring the Clinical Spectrum
CME/CE Broadcast ReplayNew Insights in the Management of HCM: Exploring the Clinical Spectrum
Milind Y. Desai, MD, MBA
Iacopo Olivotto, MD
Elena Arbelo, MD, PhD
Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection Fraction
CME/CEOptimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With Mildly Reduced or Preserved Left Ventricular Ejection Fraction
John McMurray, OBE, BSc, MB ChB (Hons), MD, FRCP, FRSE, FMedSci, FESC, FACC, FAHA, FJCS, FHFA, FHFSA, FBSH
Scott Solomon, MD
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
MinuteCE®Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
James M. Cleary, MD, PhD
